[Pharmacokinetics and pharmacodynamics of the beta-receptor blocker sotalol].
D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D001794:Blood Pressure / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects*; D002986:Clinical Trials as Topic; D005230:Fatty Acids, Nonesterified / Q000097:blood; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007545:Isoproterenol; D007668:Kidney / Q000378:metabolism*; D007773:Lactates / Q000097:blood; D009200:Myocardial Contraction / Q000187:drug effects; D011773:Pyruvates / Q000097:blood; D013015:Sotalol / Q000378:metabolism* / Q000494:pharmacology*; D013268:Stimulation, Chemical
D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D007773:Lactates; D011773:Pyruvates; D013015:Sotalol; D007545:Isoproterenol
beta-Adrenerge Wirkung von Dobutamin. Untersuchungen an Patienten mit reduzierter Kammerfunktion bei koronarer Herzerkrankung oder Kardiomyopathie.